YM BioSciences seeks $70m from public offering
This article was originally published in Scrip
Executive Summary
Canadian drug development company YM BioSciences is looking to raise $70 million in a public offering announced on 23 February, having priced 35 million common shares at $2 a share. The offering is expected to close on or around 29 February 2012.